LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 9 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $21,586,000,000 | -20.4% | 12,000,000 | 0.0% | 0.42% | +3.5% |
Q3 2016 | $27,118,000,000 | +20.4% | 12,000,000 | 0.0% | 0.40% | -17.1% |
Q2 2016 | $22,523,000,000 | +64.2% | 12,000,000 | +41.2% | 0.49% | +92.9% |
Q1 2016 | $13,714,000,000 | -8.3% | 8,500,000 | 0.0% | 0.25% | 0.0% |
Q4 2015 | $14,952,000,000 | – | 8,500,000 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 14,500,000 | $15,044,000 | 1.87% |
WOLVERINE ASSET MANAGEMENT LLC | 12,250,000 | $12,530,000 | 0.17% |
DeepCurrents Investment Group LLC | 1,000,000 | $1,107,000 | 0.10% |
Verition Fund Management LLC | 709,000 | $716,000 | 0.03% |
LAZARD ASSET MANAGEMENT LLC | 10,000,000 | $10,105,000 | 0.02% |
Citadel Advisors | 31,800,000 | $32,140,000 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS INC | 10,500,000 | $10,735,200,000 | 0.01% |
DEUTSCHE BANK AG\ | 4,500,000 | $4,525,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 2,500,000 | $2,513,000 | 0.00% |
MACKAY SHIELDS LLC | 157,000 | $159,000 | 0.00% |